Annual Drug Patent Expirations for FABHALTA
Fabhalta is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There are two patents protecting this drug.
This drug has fifty-one patent family members in thirty-eight countries.
The generic ingredient in FABHALTA is iptacopan hydrochloride. One supplier is listed for this compound. Additional details are available on the iptacopan hydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
